Repositioning and follow-up of intralenticular dexamethasone implant

We report the case of a 54-year-old man who attended our emergency department complaining of severe floaters and decreased vision in his right eye. Seven days earlier, a dexamethasone intravitreal implant (Oxurdex) had been placed for a noninfectious posterior uveitis. Slitlamp examination showed the implant had penetrated the posterior lens capsule and was lodged in the posterior cortex of the lens; a posterior cortical cataract developed subsequently. Removal of the cataract, repositioning of the implant to the posterior segment, and the postoperative course are described. To our knowledge, this is the first report of the repositioning of an intralenticular dexamethasone intravitreal implant.Financial DisclosureNeither author has a financial or proprietary interest in any material or method mentioned.